NON CONTROLLING INTEREST (Details) - USD ($)	3 Months Ended		9 Months Ended
NON CONTROLLING INTEREST (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Net loss attributable to the non-controlling interest			$ (3,108)	$ (4,195)
BioCorRx Pharmaceuticals, Inc [Member]
Net loss	$ (2,397)	$ (7,802)	$ (5,692)	$ (17,335)
Average Non-controlling interest percentage of profit/losses	24.20%	24.20%	24.20%	24.20%
Net loss attributable to the non-controlling interest	$ (580)	$ (1,888)	$ (1,378)	$ (4,195)
Joseph DeSanto MD [Member]
Net loss	$ (1,395)		$ (4,945)
Average Non-controlling interest percentage of profit/losses	35.00%		35.00%
Net loss attributable to the non-controlling interest	$ (488)		$ (1,730)